Health
US regulators to weigh controversial peptides backed by RFK Jr
The FDA is reviewing the evidence for controversial peptides promoted by Robert F. Kennedy Jr., amid rising demand for compounds marketed for sleep, muscle growth, and anti-ageing.
Coverage timeline — 1 article
Al Jazeera
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
2026-07-22 20:39 UTC